3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Pain
14
Neoplasms
6
Colonic Neoplasms
5
Agnosia
5
Lung Neoplasms
4
Head and Neck Neoplasms
4
Cancer Pain
4
Breast Neoplasms
4
Rectal Neoplasms
3
Prostatic Neoplasms
3
Pain, Postoperative
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Pancreatic Neoplasms
2
Lymphoma, Follicular
2
Diverticulosis, Colonic
2
Chronic Pain
2
Breakthrough Pain
2
post laminectomy syndrome
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Terminal Cancer
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Interventions
Furosemide
1
Fentanyl
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Dyspnea, Paroxysmal
×
Fentanyl
×
Clear all
NCT04635852
2020-11-19
EFFENDYS
University of Cologne
Phase 2
Completed
10 enrolled